GB Sciences Inc
Change company Symbol lookup
Select an option...
GBLX GB Sciences Inc
$PABEZ5T Bloomberg PAB Eurozone 50 Decrement
CXW CoreCivic Inc
CLNE Clean Energy Fuels Corp
SCGEY Shoucheng Holdings Ltd
PMT-B PennyMac Mortgage Investment Trust
PANW Palo Alto Networks Inc
MDT Medtronic PLC
NUV Nuveen Municipal Value Fund
CZOO+ Cazoo Group Equity Warrants Exp 26th Aug 2026 *W EXP 08/26/2026

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

GB Sciences, Inc. is a biopharmaceutical research and development company. The Company develops disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its wholly owned subsidiary, GbS Global Biopharma, Inc. (GBSGB). The Company's primary focus is on preparing its lead program for the treatment of the motor symptoms of Parkinson's disease (PD) in a human clinical trial. Through GBSGB, the Company is engaged in the research and development of plant-inspired medicines, with virtual operations in North America and Europe. GBSGB has a portfolio of intellectual property containing both plant-inspired formulations and its artificial intelligence (AI)-enabled drug discovery platform, as well as research contracts and various supplier arrangements. GBSGBs intellectual property covers a range of over 65 medical conditions, from which five drug development programs are in the preclinical stage of drug development.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    2:59p ET 11/30/22
  • Last (size)
  • 52-Wk Range
    0.0151 - 0.042
  • (12/20/21 - 04/01/22)
  • 125.4%
  • Market Cap
  • Shares Outstanding
  • 0.00
  • 48.08x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.5
  • 0.00
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.